V-Bio Ventures is a Ghent life sciences VC that co-creates and invests in early- to mid-stage therapeutics companies, with a preferred relationship to VIB. Portfolio company Animab closed a €10M Series B in July 2025.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.